Pain Stories In The News
Webcast addresses how persistent chronic pain can impact relationships
November 13, 2008 [Source: American Society of Pain Educators (ASPE)]
The American Society of Pain Educators (ASPE) launches today the third and final of a three-part educational Webcast series: Making Sure Your Relationships Aren't Pained When You're in Chronic Pain at www.painawareness.org. This Webcast addresses the psychological effects of chronic pain, in particular the stress it may cause on everyday relationships. Story
Foot Problems common among people with diabetes
November 11, 2008 [Source: Health Behavior News Service]
About 60 to 70 percent of all patients that develop diabetes in their lifetime will have some form of neuropathy, which is the loss of protective sensation, and therefore, increases their risk of having a foot problem. Knowing some of the warning signs of the problems dealing with my feet and taking care of those things immediately I knew would prevent larger issues Story
The ACCORD Program: working together for the management of chronic pain - a first in Quebec: $2.5M from the Canadian Institutes of Health Research
November 5, 2008 [Source: ACCORD Program]
A group of researchers from Montreal, Sherbrooke and McGill universities created a community alliance with clinicians, healthcare professionals and the Quebec Chronic Pain Association
(AQDC) (www.chronicpainquebec.org) to improve the evaluation and treatment of
chronic pain in Quebec.
Story
Doctors stress pressing need for research into the best treatment for medication overuse headaches
November 3, 2008 [Source: Cephalalgia]
There is a critical need to review current treatment strategies for the increasingly common problem of medication overuse headaches (MOH), according to a series of international papers in the November issue of Cephalalgia. In the United States, 60 per cent of people with chronic daily headaches attending headache clinics have MOH. Data from a physician study suggests that it may be the third most frequent type of headache after migraines and tension-type headaches. Story
ACOEM issues treatment guidelines for workers with chronic pain
October 30, 2008 [Source: American College of Occupational and Environmental Medicine]
The American College of Occupational and Environmental Medicine has published new medical treatment guidelines for providing care to workers with chronic pain. More than 200 recommendations are outlined in the new evidence-based guidelines, which were developed by a multi-disciplinary panel of national experts and were reviewed by representatives of leading medical and health organizations. Story
Adequate pain care sorely lacking for patients
October 29, 2008 [Source: McClatchy Newspapers]
Medical science has learned a great deal about the causes of pain and ways to relieve it, pain experts say, but for a host of reasons, the treatment of pain and suffering has improved hardly at all in recent years. Story
TMJ pain & teeth grinding on the rise amid economic and election stress
October 28, 2008 [Source: Holistic Technologies]
More than 3 million Americans suffer pain every day from teeth grinding and clenching (bruxism), and the recent worries about the election and the economy seem to be exacerbating the problem. Data from the makers of the SleepGuard biofeedback headband, which helps free people from TMJ pain, shows a dramatic increase in sales resulting from increased stress. Story
From pain to unexpected fame: one woman's journey to know fibro
Martha Beck and leading experts join together to help people living with fibromyalgia
October 27, 2008 Source: Eli Lily
October 27, 2008 [Source: Eli Lily]
Living in pain for one day can be excruciating, but for Martha Beck, one day became a seemingly endless cycle of widespread pain, fatigue, emotional changes, and memory problems. In an effort to help the 5 million Americans with fibromyalgia(1) play an active role in the management of their disorder, Beck is, for the first time, publicly sharing her personal journey by spearheading Know Fibro, a national initiative that provides comprehensive fibromyalgia informatio, and an interactive Web site, www.KnowFibro.com. Story
Johns Hopkins And National Fibromyalgia Association launch fibromyalgia educational initiative to bridge chasm in diagnosis and care
October 27, 2008 [Source: National Fibromyalgia Association]
The Johns Hopkins University School of Medicine, The Institute for Johns Hopkins Nursing and the National Fibromyalgia Association are launching the Fibromyalgia Circle of Care Initiative. The outcomes-based educational initiative will educate providers about the disease state and the latest therapeutic options; thus, driving accurate and early diagnosis of fibromyalgia for the ten million U.S. citizens impacted by this disorder. Story
NanoVibronix receives FDA clearance for its PainShield(TM) MD device
October 23, 2008 [Source: NanoVibronix]
NanoVibronix, a medical device company, announced that the US Food and Drug Administration has granted clearance to market PainShield MD, a diathermy device used to treat pain. PainShield is the first hands-free, patch-based diathermy device, thus allowing for an entirely new dimension in ultrasound treatment of pain and soft tissue healing. Story
NICE approves spinal cord stimulation for chronic neuropathic pain, UK
October 22, 2008 [Source: Medtronic]
The new guidance from the National Institute for Health and Clinical Excellence [UK] recommends that Spinal Cord Stimulation should be made available to all patients who continue to experience chronic neuropathic pain for at least 6 months despite trying conventional approaches to pain management. Story
Foot pain? You may have diabetes
October 22, 2008 [Source: American College of Foot and Ankle Surgeons]
Do you ever feel burning, tingling or numbness in your feet and toes? The American College of Foot and Ankle Surgeons (ACFAS) warns against ignoring these symptoms. They could be a warning sign of diabetes and may be caused by a condition called diabetic peripheral neuropathy, or nerve damage. Story
NeurogesX submits NDA for NGX-4010 dermal capsaicin patch for treatment of postherpetic neuralgia (PHN)
October 22, 2008 [Source: NeurogesX, Inc]
The NDA submission is supported by twopivotal studies of NGX-4010 in patients with PHN. The results of these clinical trials show a statistically significant reduction in pain from
baseline for up to 12 weeks after a single 60-minute application of the
dermal patch. In these studies, NGX-4010 could be administered either as a
monotherapy or in combination with other systemic neuropathic pain
medications.
Story
AbsolutelyNew licenses The Headache Reliever™ treatment band
October 21, 2008 [Source: AbsolutelyNew]
True to its name, The Headache Reliever is clinically proven to reduce tension and migraine headache pain without drugs and their side-effects. It does this via: A pressure band that gently compresses blood vessels, reusable, microwavable hot packs that relax muscles, and reusable, freezer-friendly cold packs that cool and constrict blood vessels. Story
Troops' pain meds raise concerns
October 21, 2008 [Source: USA TODAY]
Narcotic pain-relief prescriptions for injured U.S. troops have jumped from 30,000 a month to 50,000 since the Iraq war began, raising concerns about the drugs' potential abuse and addiction, says a leading Army pain expert. Story
IASP declares Global Year Against Cancer Pain - "Raising Awareness, Improving Treatment, Growing Support" campaign
October 20, 2008 [Source: IASP]
The International Association for the Study of Pain launches its Global Year Against Cancer Pain today. Scheduled through mid-October 2009, the campaign will draw attention to pain and suffering experienced by people with cancer. Under the theme of "Raising Awareness, Improving Treatment, Growing Support," IASP members and chapters will hold lectures, training sessions, and other events to highlight issues in cancer pain. Story
Teva announces FDA approval and commercial launch of Fentanyl Transdermal System
October 20, 2008 [Source: Teva Pharmaceutical Industries]
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that the U.S. Food and Drug Administration has granted approval for the Company’s Abbreviated New Drug Application (ANDA) for Fentanyl Transdermal System, 25 mcg/hour, 50 mcg/hour, 75 mcg/hour and 100 mcg/hour, the AB-rated generic equivalent of Ortho McNeil’s chronic pain treatment Duragesic®. Shipment of this product has commenced Story
Pfizer reaches agreements in principle to resolve litigation involving its NSAID
October 17, 2008 [Source: Pfizer Inc.]
Pfizer Inc announced today that it has reached agreements in principle to resolve substantially all of the personal injury cases, consumer fraud cases and state attorneys general claims involving its non-steroidal anti-inflammatory (NSAID) pain medication Bextra, which Pfizer voluntarily withdrew from the U.S. market in 2005. Additionally, following key court rulings in favor of Celebrex, claims regarding Celebrex, an effective pain treatment for millions of patients, will also be resolved as part of the settlement.
Story |
